Changzhou No.2 People's Hospital
29
8
8
4
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
0.0%
0 terminated/withdrawn out of 29 trials
100.0%
+13.4% vs industry average
21%
6 trials in Phase 3/4
0%
0 of 4 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (29)
A Survey of Public Attitudes Towards Gallbladder-preserving Lithotomy and Its Influencing Factors
Role: lead
Mazdutide in Type 2 Diabetes With Early-Stage Cognitive Impairment (LIGHT-COG Study)
Role: collaborator
Pirtobrutinib+Sonrotoclax（PS) Regimen in the Treatment of B-Cell Lymphoma
Role: lead
LIGHT-MCI Trial: GLP-1 Agonist, SGLT2 Inhibitor, and DPP-4 Inhibitor for MCI Remission in Type 2 Diabetes
Role: collaborator
Pirtobrutinib+Pola-R-CHP for Newly Diagnosed Non-GCB DLBCL
Role: lead
Pirtobrutinib + R-CHOP for Untreated Non-GCB DLBCL
Role: lead
A Prospective, Single-Arm, Multicenter Clinical Study of High-Risk Localized and Locally Advanced Renal Clear Cell Carcinoma
Role: collaborator
UCAR T-cell Therapy Targeting CD19/ BCMA in Patients With Relapse/ Refractory Autoimmune Diseases
Role: lead
Effectiveness of Multimedia Health Education to Reduce Anxiety in Patients With Vitreous Floaters
Role: lead
An Clinical Study of CD19 CAR NK Cells for the Treatment of Refractory Primary Immune Thrombocytopenia
Role: lead
Steerable vs Conventional FANS for <2cm Lower Pole Stone Treatment: SCULPT Trial
Role: collaborator
FMT+SOX+Sintilimab As First-line Treatment for Advanced Gastric Cancer
Role: lead
FMT+Immunotherapy+Chemotherapy As First-line Treatment for Driver-gene Negative Advanced NSCLC
Role: lead
Effectiveness and Safety of 25-Gauge Needle-Assisted Phacoemulsification of Dislocated Intravitreal Lens Nucleus
Role: lead
γδ T-PD-1 Ab Cells in the Treatment of Advanced Solid Tumors
Role: lead
Prediction and Prognostic Analysis of Liver Abscess Formation After Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma (CHANCE 2407)
Role: collaborator
An Clinical Study of NKG2D-CAR-NK Cells for the Treatment of Refractory Recurrent Multiple Myeloma
Role: lead
Molecular Markers in Predicting Response to Treatment in FH-deficient RCC Patients
Role: collaborator
The Efficacy and Safety of ZR2 Versus R-miniCHOP in the Treatment of Unfit or Frail de Novo Diffuse Large B-cell Lymphoma Patients Aged Older Than or Equal to 70 Years
Role: collaborator
Chinese Research Group of Gallbladder Cancer
Role: collaborator